Avanalav tablets 50 mg blister No. 4

Avanalav® tablets are used to treat erectile dysfunction in adult men. Sexual stimulation is required for Avanalav® to be effective.

Composition

Active ingredient: avanafil.

1 tablet contains - 50 mg of avanafil.

Excipients: mannitol (E 421), fumaric acid, hydroxypropyl cellulose, low-substituted hydroxypropyl cellulose, calcium carbonate, magnesium stearate, yellow iron oxide (E 172).

Contraindication

Hypersensitivity to the active substance or to any of the excipients of the drug.

The use of avanafil is contraindicated in the following categories of patients:

Method of application

The recommended dose is 100 mg, taken as needed approximately 15-30 minutes before sexual activity. Based on individual efficacy and tolerability, the dose may be increased to a maximum of 200 mg or decreased to 50 mg. The maximum recommended frequency of administration is once daily. Sexual stimulation is required to achieve a response to treatment.

Application features

Children

Not prescribed to children (under 18 years of age).

Overdose

In cases of overdose, standard supportive measures should be employed as necessary. Hemodialysis is not expected to accelerate the clearance of avanafil, as avanafil is extensively bound to plasma proteins and is not excreted in the urine.

Avanafil has been administered to healthy volunteers in single doses of up to 800 mg and to patients in multiple doses of up to 300 mg per day. Adverse reactions were similar to those observed with lower doses, but their frequency and severity increased.

Side effects

Increased liver enzymes, abnormal electrocardiogram, increased heart rate, increased blood pressure, blood in the urine, heart murmur, increased prostate-specific antigen, weight gain, increased bilirubin in the blood, increased creatinine in the blood, increased body temperature.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 2 years.